DLL3, Human (Rovalpituzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-DLL3, Human (Rovalpituzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityDLL3, Human (Rovalpituzumab biosimilar)
CloneRovalpituzumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human DLL3 Recombinant Antibody. Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial.
Immunogenn/a
Other NamesAnti-DLL3 Recombinant Antibody, Research Grade Rovalpituzumab, Anti-Human DLL3 Recombinant Antibody, , Antibody Drug Analogues, Monoclonal Antibody, YR1386, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1613313-01-1
Catalog #YR1386
Priceplease inquire
Order / More InfoDLL3, Human (Rovalpituzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.